Background: Current rates of opioid prescribing have deleterious consequences on both patient and societal levels. This study aims to evaluate responsible opioid prescribing and predictors of opioid consumption in immediate implant-based breast reconstruction. Methods: Patients undergoing consultation for immediate, implant-based breast reconstruction were enrolled in a prospective, cohort survey study. A survey was administered at the preoperative and postoperative appointment to collect data on pain expectations and opioid use. A medical record review was performed. Results: Of 100 enrolled patients, 97 (97.0 percent) underwent surgery and 85 (85.0 percent) completed the postoperative survey. Preoperatively, 27 patients (27.0 percent) had a history of a chronic pain syndrome, 34 (34.0 percent) had a history of a mental health comorbidity, and nine (9.0 percent) had a history of active preoperative opioid use. A total of 85 tissue expander (87.6 percent) and 12 direct-to-implant (12.4 percent) reconstructions were completed. Patients were prescribed an average of 36.0 5-mg oxycodone tablets postoperatively. Patients reported consuming an average of 20.6 tablets, or 57.0 percent of the average prescription amount. The majority of patients (75.3 percent) reported taking an opioid less than once per day at the time of survey completion, and 24 patients (28.2 percent) reported that they did not use any opioids postoperatively. Preoperative opioid use (p= 0.004), inpatient opioid consumption (p< 0.0001), and patient-reported anxiety related to pain control (p< 0.05) were predictors of opioid consumption. Conclusions: Patients undergoing mastectomy and implant-based breast reconstruction are prescribed nearly twice as many opioid tablets as consumed, and one in three patients report not using any opioids postoperatively. Clinical factors may help guide prescribing practices.
The United States Medical Licensing Exam® (USMLE®) Step 1 exam implemented pass/fail scoring to "create a more holistic residency application selection process." We aimed to assess whether this transition favored holistic review or redirected emphasis to other metrics. Quantifiable data from 330 Plastic Surgery Common Applications (PSCAs) submitted to a single academic center were collected. Applicants were stratified into 2 groups based on numeric or pass/fail Step 1 score. Logistic regression was performed for each group to assess the odds of matching based on quantifiable application components. 2023-2024 Match cycle. 330 integrated plastic surgery applicants. A total of 137 applications reported numeric Step 1 scores, while 193 reported pass/fail scores. For applicants with a numeric Step 1 score, the factors most predictive of matching were Step 2 score >265 (OR 159 [95% CI, 6.6-999], Step 1 Score between 240 and 250 (OR 21.8 [95% CI, 4.8-98.6]), and being a U.S. citizen (OR 21.1 [95% CI, 3.9-116]). Letter of recommendation numeric strength (OR 11.0 [95% CI, 2.7-45.6]) was also a significant match predictor, followed by more than 16 podium presentations (OR 10.8 [95% CI, 2.6-45.5]). In comparison, for students with pass/fail Step 1 scores, there were only 3 significant factors that predicted a successful match: strength of recommendation letters (OR 3.7 [95% CI, 1.8-7.6]), Alpha Omega Alpha society membership (OR 3.2 [95% CI, 1.3-7.7]), and graduation from a U.S News and World Report top 40 medical school in research (OR 3.0 [95% CI, 1.5-6.1]). For applicants with a numeric Step 1 score, Step 1 and 2 scores remained the most critical match factors. In comparison, letter of recommendation strength and graduation from a top 40 medical school were most important for applicants with pass/fail scoring, indicating a shift toward other application metrics following the scoring change.
Although there has been a recent focus on decreasing opioid prescribing through alternative pain medication protocols, the patient's perception of pain related to breast reconstructive surgeries has not been well described. We sought to evaluate patient perception of pain control as it influences opioid use. We hypothesize that modifiable factors may influence patterns in pain perception and postoperative opioid use. Patients undergoing consultation for mastectomy with immediate, implant-based breast reconstruction were enrolled in a prospective, cohort survey study. A survey was administered at preoperative and postoperative appointments to collect data on pain expectations and pain control. Of 100 patients enrolled, 85% completed the postoperative survey. Over half of patients (52%) reported feeling anxious about pain control after surgery. Patients with preoperative opioid use were more likely to expect complete relief of pain postoperatively (P = .038). Patients with psychiatric comorbidity were more likely to report feeling anxious about postoperative pain (P = .012; 70% vs 42%; OR 3.0 CI 1.2-7.4). Patients who reported feeling anxious about pain control preoperatively were more likely to report trying opioids (P = .047; 67% vs 44%; OR 2.5 CI 1.0-6.1) and benzodiazepines (P = .020; 80% vs 56%; OR 3.0 CI 1.2-8.0) postoperatively. Anxiety related to pain control is common and results in an increased likelihood of trying opioid and benzodiazepine medications postoperatively. This presents an opportunity to educate patients preoperatively by addressing anxiety related to pain control to decrease controlled substance use.
Lower extremity ulcers have significant morbidity, with treatment determined by the underlying disorder. Reported is a 32-year-old female presenting with small skin nodules and bruises across her legs 4 weeks following her second COVID vaccination. These lesions progressed into large, necrotic ulcers over several months. Initial work-up showed widespread pannicular thrombotic vasculopathy with ischemic skin necrosis. The tissue was negative for calcification on Von Kossa histochemistry, and a working diagnosis of subcutaneous thrombotic vasculopathy was suggested. The ulcers progressed despite treatments with corticosteroids, therapeutic anticoagulation, intravenous immunoglobulin, plasmapheresis, sodium thiosulfate, wound care, and repeat debridement. Later debridement specimens demonstrated rare vascular and pannicular calcifications. This finding supports the hypothesis that subcutaneous thrombotic vasculopathy is a precursor to calciphylaxis, the patient’s current working diagnosis. However, based on the patient’s entire clinical picture, a definitive diagnosis has yet to be found. This report highlights the challenges of working with rare diseases and the importance of multidisciplinary cooperation.
1 March 2015 in Plastic and Reconstructive Surgery - Global Open